{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:05:03Z","timestamp":1757451903096,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>We aimed to analyze the clinico-pathological and molecular features of mesonephric-like adenocarcinoma (MLA) to enhance understanding of this tumor type.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is the first case of MLA occurring in the retroperitoneum of a male patient. Clinico-pathological and molecular characteristics were analyzed, and the relevant literature was reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A 65-year-old elderly male was admitted to the hospital with mild bilateral dull pain in the lumbar region for more than 1 month, accompanied by a feeling of dysuria. CT tomography revealed a retroperitoneal tumor. While tumor immuno-histochemistry was positive for CK, CK7, Vimentin, PAX-8, CD10, GATA-3, EMA, and CR to varying degrees, it was negative for P53, WT-1, HMB45, MelanA, CD117, DOG-1, CD34, S-100, ER, PR, AR, CEA, \u03b1-inhibin and TTF-1. Ki67 index was &amp;lt;10% in most areas and was approximately 30% in the hotspot areas in the glandular ductal region. Molecular detection (Next-generation sequencing method, 425-gene panel from NanjingShihe Gene Biotechnology Co., Ltd. for targeted DNA enrichment): No clinically significant variants detected. The final pathological diagnosis was a retroperitoneal malignant tumor consistent with a well-moderately differentiated MLA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MLA in the retroperitoneum of men has not been reported yet. The diverse morphology and unclear molecular characteristics of this tumor mandate careful diagnosis for good clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1433563","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:10:23Z","timestamp":1730095823000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: The first known case of male retroperitoneal mesonephric-like adenocarcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Baohong","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/PGP.0000000000000167","article-title":"Differential expression patterns of G A T A 3 in uterine mesonephric and nonmesonephric lesions","volume":"34","author":"Roma","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000471","article-title":"G A T A 3 is a sensitive and specific marker of benign and Malignant mesonephric lesions in the lower female genital tract","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03632.x","article-title":"p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection","volume":"57","author":"Houghton","year":"2010","journal-title":"Histopathology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/PAP.0000000000000095","article-title":"Recent Developments in Non-HPV-related adenocarcinomas of the lower female genital tract and their precursors","volume":"23","author":"McCluggage","year":"2016","journal-title":"Adv Anat Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/his.2012.62.issue-1","article-title":"New development in endocervical glandular lesions","volume":"62","author":"McCluggage","year":"2013","journal-title":"Histopathology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric Adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.08.031","article-title":"Mesonephric adenocarcinoma of the cervix: A case report and review of the literature","volume":"103","author":"Yap","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.v127.8","article-title":"Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation","volume":"127","author":"Kezlarian","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13000-017-0655-y","article-title":"Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: A case report and literature review","volume":"12","author":"Ando","year":"2017","journal-title":"Diagn Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/1066896915611489","article-title":"Mesonephric adenocarcinoma of the uterine corpus: A case report and diagnostic pitfall","volume":"24","author":"Kim","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2016.55.02.22","article-title":"Mesonephric adenocarcinoma of endocervix with lobular mesonephric hyperplasia: Case report","volume":"55","author":"Puljiz","year":"2016","journal-title":"Acta Clin Groat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199510000-00006","article-title":"Malignant mesonephric tumor of the cervix with an initial manifestation as pulmonary metastasis: Case report and review of the literature","volume":"37","author":"Yeo","year":"2016","journal-title":"Eur J Gynaecol Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-016-1004-x","article-title":"Mesonephric adenocarcinoma of the vagina: Diagnosis and multimodal treatment of a rare rumor and analysis of worldwide experience","volume":"192","author":"Iris","year":"2016","journal-title":"Strahlentherapie Und Onkol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.01143.x","article-title":"A case of mesonephric adenocarcinoma of the vagina with a 1-yearfollow-up","volume":"18","author":"Bifulco","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterinecervix and vagina: Report of 2 cases with immunohistochemicalpositivity For PAX 2, PAX8, and GATA -3","volume":"33","author":"Roma","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_298_20","article-title":"Mesonephric adenocarcinoma of the uterine corpus","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(03)00228-2","article-title":"Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus","volume":"90","author":"Montagut","year":"2003","journal-title":"Gynecol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2012.06.009","article-title":"Large mesonephric cyst with acute adnexal torsion in a teenage girl","volume":"25","author":"Akkawi","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1746-1596-8-74","article-title":"Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature","volume":"8","author":"Meguro","year":"2013","journal-title":"Diagn Pathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000493","article-title":"Mesonephric adenocarcinoma of the uterine corpus: report of 2 cases and review of the literature","volume":"38","author":"Zhang","year":"2019","journal-title":"Inter J Gynecol Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"bcr-2018-224758","DOI":"10.1136\/bcr-2018-224758","article-title":"Sultan A H.Mesonephric adenocarcinoma of the vagina masquerading as a suburethral cyst","author":"Shoeir","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract","volume":"42","author":"Mirkovic","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200605000-00079","article-title":"Second case of uterine mesonephric adenocarcinoma","volume":"16","author":"Marquette","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e318166067f","article-title":"Mesonephric adenocarcinoma of the uterine corpus:a case report and review of the literature","volume":"27","author":"Wani","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200112000-00011","article-title":"Mesonephric adenocarcinoma of the uterine corpus:CD10 expression as evidence of mesonephric differentiation","volume":"25","author":"Ordi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive TTF1 and hepatocyte nuclear factor 1-\u03b2","volume":"36","author":"Kenny","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000306","article-title":"Mixed mesonephric adenocarcinoma and high-grade neuroendocrine carcinoma of the uterine cervix: case description of a previously entity with insight into its molecular pathogenesis","volume":"36","author":"Cavalcanti","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.gore.2016.05.002","article-title":"Mesonephric adenocarcinoma of the cervix: case report and literature review","volume":"17","author":"Dierickx","year":"2016","journal-title":"Gynecol Oncol Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1433563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:10:27Z","timestamp":1730095827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1433563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":30,"alternative-id":["10.3389\/fonc.2024.1433563"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1433563","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"article-number":"1433563"}}